Abstract

A microbe is a microscopic organism which may exists in its single-celled form or in a colony of cells. In recent years, accumulating researchers have been engaged in the field of uncovering microbe-disease associations since microbes are found to be closely related to the prevention, diagnosis, and treatment of many complex human diseases. As an effective supplement to the traditional experiment, more and more computational models based on various algorithms have been proposed for microbe-disease association prediction to improve efficiency and cost savings. In this work, we developed a novel predictive model of Graph Regularized Non-negative Matrix Factorization for Human Microbe-Disease Association prediction (GRNMFHMDA). Initially, microbe similarity and disease similarity were constructed on the basis of the symptom-based disease similarity and Gaussian interaction profile kernel similarity for microbes and diseases. Subsequently, it is worth noting that we utilized a preprocessing step in which unknown microbe-disease pairs were assigned associated likelihood scores to avoid the possible negative impact on the prediction performance. Finally, we implemented a graph regularized non-negative matrix factorization framework to identify potential associations for all diseases simultaneously. To assess the performance of our model, cross validations including global leave-one-out cross validation (LOOCV) and local LOOCV were implemented. The AUCs of 0.8715 (global LOOCV) and 0.7898 (local LOOCV) proved the reliable performance of our computational model. In addition, we carried out two types of case studies on three different human diseases to further analyze the prediction performance of GRNMFHMDA, in which most of the top 10 predicted disease-related microbes were verified by database HMDAD or experimental literatures.

Highlights

  • Antonie Van Leeuwenhoek, the father of microbiology, was the first to discover, observe, describe, study, and conduct scientific experiments with microbes, using simple single-lensed microscopes of his own design in 1673 (Leeuwenhoek, 1683-1775)

  • For the global leave-one-out cross validation (LOOCV), each of the known microbe-disease associations was in turn considered to be the test sample while the remaining known associations were treated as the training samples

  • All of the unknown microbe-disease pairs were regarded as the candidate samples which would be used in the ranking process

Read more

Summary

Introduction

Antonie Van Leeuwenhoek, the father of microbiology, was the first to discover, observe, describe, study, and conduct scientific experiments with microbes, using simple single-lensed microscopes of his own design in 1673 (Leeuwenhoek, 1683-1775). Galiana et al (2014) found that Actinomyces can be as an indicator in the evolution of chronic obstructive pulmonary disease (COPD) patients because their study confirmed a strong association between the presence or absence of Actinomyces and the severity of the clinical condition. Another example is that periodontal pathogens Porphyromonas gingivalis and Fusobacterium nucleatum stimulate tumorigenesis of oral squamous cell carcinoma (OSCC) via direct interaction with oral epithelial cells through Toll-like receptors which is beneficial to the development of corresponding prevention and treatment schemes (Binder Gallimidi et al, 2015). Many feasible and effective prediction models have been developed by researchers

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.